Molecular Medicine Today logo Elsevier logo

Publisher: Elsevier

Related content
Volume 5, Number 2, 1 February 1999

< previous issue | all issues | next issue >

Targeting protein breakdown to treat cancer
pp. 48-49(2)
Author: Bonn D.

Virus buster for transfusion blood
pp. 49-50(2)
Author: Dorrell S.

Turning off RB for a healthy heart?
pp. 50-51(2)
Author: Fricker J.

New light on retinal gene therapy
pp. 52-52(1)
Author: Aldred M.A.

Tolerating adenoviral vectors
pp. 53-53(1)
Author: Caplan N.J.

Alcoholic mice shed light on the human condition
pp. 53-53(1)
Author: Evans K.L.

The importance of location
pp. 54-54(1)
Author: Lindsay J.

Is extravasation a Fas-regulated process?
pp. 61-67(7)
Authors: Walsh K.; Sata M.

Urinary analyte screening: a noninvasive detection method for Down syndrome?
pp. 68-73(6)
Authors: Canick J.A.; Kellner L.H.; Cole L.A.; Cuckle H.S.

New perspectives on the etiology of systemic sclerosis
pp. 74-78(5)
Authors: Artlett C.M.; Smith J.B.; Jimenez S.A.

Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer
pp. 86-94(9)
Authors: van Steeg H.; Kraemer K.H.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page